Citation

Pani PP, Maremmani AGI, Pacini M, Trogu E, Gessa GL, Ruiz P, Maremmani I. J. Clin. Med. 2020; 9(6): 1-19.

Copyright

(Copyright © 2020, MDPI: Multidisciplinary Digital Publishing Institute)

DOI

10.3390/jcm9061913

PMID

unavailable

Abstract

The diagnosis of substance use disorder is currently based on the presence of specifically identified behavioral symptoms. In addition, other psychiatric signs and symptoms accompany addictive behavior, contributing to the full picture of patients' psychopathologic profile. Historically, such symptoms were confined within the framework of "comorbidity", as comorbid psychiatric disorders or personality traits. However, an alternative unitary view of the psychopathology of addiction, inclusive of related psychiatric symptoms, has been claimed, with the support of epidemiological, neurobiological, and neuropsychological evidence. In the present article, we highlight the research advancements that strengthen this unified perspective. We then give an account of our group's definition of a specific SCL-90-based construct of the psychopathology of addiction. Lastly, we discuss the benefits that can be expected to be acquired in the evaluation and treatment of patients with a longitudinal approach including psychological/psychiatric predisposing features, addictive behavior, and psychiatric manifestations. © 2020 by the authors; licensee MDPI, Basel, Switzerland.

Language: en

Keywords

human; violence; mental health; suicide; systematic review; prevalence; anxiety; psychosis; personality; addiction; Addiction; Psychiatric comorbidity; risk factor; mental disease; questionnaire; psychiatrist; behavior; discriminant analysis; impulsiveness; irritability; somatization; prospective study; neurobiology; clinical study; emotionality; Article; neurophysiology; psychomotor activity; Psychopathology specific to substance use disorders